Inflammatory bowel disease activity measured by positron-emission tomography [2]

Lancet

Volumn 350, Issue 9073, 1997, Pages 262-

  Bicik, I ^a   Bauerfeind, P ^a   Breitbach, T ^a   Von Schulthess, G K ^a   Fried, M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CLINICAL ARTICLE; ENTERITIS; HUMAN; LETTER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030858922     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62225-8     Document Type: Article

References (4)

1. WR Best JM Becktel JW Singleton FJ Kern Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study Gastroenterology 70 1976 439 444
2. D Rachmilewitz Coated mesalazine (5-aminosalicyclic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial BMJ 298 1989 82 86
3. RA Hawkins C Hoh J Glaspy The role of positron emission tomography in oncology and other whole-body applications Semin Nucl Med 22 1992 268 284
4. R Kubota K Kubota S Yamada M Tada T Ido N Tamahashi Microautoradiographic study for the differentiation of intratumor macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake J Nucl Med 35 1994 104 112